Skip to main content
. 2023 Aug 31;29(9):2325–2333. doi: 10.1038/s41591-023-02517-y

Fig. 2. Solicited local and systemic adverse reactions.

Fig. 2

Percentages of participants who had solicited local or systemic adverse reactions within 7 days by grade after the 50 µg mRNA-1273.222 second booster dose (left) and mRNA-1273 historical group (right) at day 91 (ref. 6) in the solicited safety sets.